From Niche Therapy to Cultural Obsession
Testosterone has shifted from a specialist hormone treatment to a cultural obsession and lifestyle product. Prescriptions have exploded, rising from fewer than 1 million in 2000 to nearly 12 million in 2025, with that figure likely undercounting men who now obtain testosterone replacement therapy (TRT) through telehealth platforms rather than traditional clinics. High‑profile figures and podcasters discuss their regimens openly, while images of muscular entrepreneurs and older public officials touting their injections reinforce the idea that more testosterone equals more vitality, productivity and power. At the same time, online men’s health companies frame tiredness, irritability and flagging drive as symptoms of a fixable hormonal deficit. This overlap of aspirational wellness culture, celebrity endorsement and easy digital prescribing has created a powerful narrative: if you feel less than your best, it might be “low T” – and an injection could restore who you “really” are.
How ‘Low T’ Became a Marketable Condition
Men’s health marketing has turned low testosterone diagnosis into a consumer journey that begins on social media. Companies such as Voy, Hims and Numan target scrolling users with ads asking if they feel irritable, unmotivated or less confident, implying that these non‑specific complaints may signal low T. Because direct advertising of testosterone itself is restricted in some jurisdictions, these firms promote blood tests instead, funnelling men into teleconsultations that can quickly lead to TRT prescriptions. Influencers like Nick Dooley then showcase dramatic before‑and‑after transformations: weight loss, renewed energy, vanished anxiety. His story, and others like it, circulate on TikTok and Reddit, reinforcing the idea that modern life is quietly draining men’s hormones. Critics argue this approach risks pathologising normal fluctuations in mood and aging, effectively inventing a “pseudo‑disease” to sell subscriptions and injections rather than addressing lifestyle factors and underlying health problems.
The Medical Reality: Hypogonadism Versus Lifestyle Fatigue
Clinically, testosterone deficiency is known as hypogonadism, and it is more complex than a single blood test. Endocrinologists emphasise that natural testosterone levels vary widely among men, and that a true low testosterone diagnosis requires both persistently low levels and specific symptoms, such as loss of morning erections, low libido, infertility, weight gain, osteoporosis or significant depression. Guidance from health systems typically defines a broad “normal” range, meaning some men flagged as low by private clinics still fall within standard boundaries in public care. Specialists worry that broadening the definition of deficiency to include any man with borderline numbers and vague complaints conflates serious hormonal disease with lifestyle fatigue, stress or poor sleep. While some patients with genuine hypogonadism experience life‑changing improvement on TRT, doctors report being inundated by younger men seeking treatment on the basis of online tests and influencer narratives rather than robust clinical assessment.
Masculinity, Politics and the ‘T-Maxxing’ Ideology
Beyond medicine, testosterone has become a charged symbol in contemporary debates over masculinity and vitality. In online fitness communities, “T‑maxxing” describes efforts to push testosterone as high as possible through intense training, strict diets and sometimes steroids. In more ideological corners of the internet, “low T” is used as an insult, equated with weakness or being a “beta”, while high testosterone is associated with dominance and decisiveness. Public officials and celebrities discussing their own TRT as part of anti‑ageing regimens feed the impression that responsible, ambitious men will optimise their hormones. This politicised framing blurs the line between a legitimate endocrine treatment and a badge of cultural identity. It also risks pressuring men who feel insecure or anxious into viewing TRT as a shortcut to confidence or status, even when their symptoms might be better addressed through mental health care, exercise, or addressing social and economic stressors.
A Growing Backlash From Clinicians
As testosterone treatment hype grows, medical professionals are sounding alarms about overdiagnosis, overtreatment and long‑term risks. Endocrinologists report clinic backlogs as more men arrive, primed by men’s health marketing to request TRT. Some specialists describe the surge as being driven less by genuine disease prevalence than by aggressive messaging that encourages men to interpret everyday tiredness or midlife dissatisfaction as hormonal failure. They worry that once men begin long‑term injections, natural production can shut down, effectively locking patients into ongoing therapy for a condition that may never have required medication. At the same time, advocates argue that traditional systems have long underdiagnosed real cases of hypogonadism, leaving many to suffer unnecessarily. The emerging consensus among cautious clinicians is not to demonise testosterone replacement therapy, but to insist on stricter diagnostic criteria, repeat testing and clear communication about risks, benefits and alternatives before prescribing.